A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00650429 · COMPLETED
Trial details
- NCT number
- NCT00650429
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.